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Abstract
An overdose of Isoproterenol (ISO) causes acute cardiomyocyte (CM) dropout and activates the resident cardiac c-
kitpos stem/progenitor cells (CSCs) generating a burst of new CM formation that replaces those lost to ISO. Recently,
unsuccessful attempts to reproduce these ﬁndings using c-kitCre knock-in (KI) mouse models were reported. We tested
whether c-kit haploinsufﬁciency in c-kitCreKI mice was the cause of the discrepant results in response to ISO. Male
C57BL/6J wild-type (wt) mice and c-kitCreKI mice were given a single dose of ISO (200 and/or 400 mg/Kg s.c.). CM
formation was measured with different doses and duration of BrdU or EdU. We compared the myogenic and
regenerative potential of the c-kitCreCSCs with wtCSCs. Acute ISO overdose causes LV dysfunction with dose-
dependent CM death by necrosis and apoptosis, whose intensity follows a basal-apical and epicardium to sub-
endocardium gradient, with the most severe damage conﬁned to the apical sub-endocardium. The damage triggers
signiﬁcant new CM formation mainly in the apical sub-endocardial layer. c-kit haploinsufﬁciency caused by c-kitCreKIs
severely affects CSCs myogenic potential. c-kitCreKI mice post-ISO fail to respond with CSC activation and show
reduced CM formation and suffer chronic cardiac dysfunction. Transplantation of wtCSCs rescued the defective
regenerative cardiac phenotype of c-kitCreKI mice. Furthermore, BAC-mediated transgenesis of a single c-kit gene copy
normalized the functional diploid c-kit content of c-kitCreKI CSCs and fully restored their regenerative competence.
Overall, these data show that c-kit haploinsufﬁciency impairs the endogenous cardioregenerative response after injury
affecting CSC activation and CM replacement. Repopulation of c-kit haploinsufﬁcient myocardial tissue with wtCSCs as
well c-kit gene deﬁcit correction of haploinsufﬁcient CSCs restores CM replacement and functional cardiac repair. Thus,
adult neo-cardiomyogenesis depends on and requires a diploid level of c-kit.
Introduction
The lack of curative therapies for heart failure (HF)1 has
made the search for an effective cellular replacement of
lost/damaged cardiomyocytes (CMs) a priority in the war
against HF epidemics1,2. Ex-vivo expanded resident car-
diac stem cells (CSCs) and progenitor cells have been
reproducibly shown to repair extensive myocardial
damage and regenerate lost CMs3–6. Nevertheless, it is
argued7–9 that the myocardium lacks a bona ﬁde endo-
genous CM-generating progenitor cell population of
biological signiﬁcance.
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This controversy has been mainly nurtured by Cre-lox
mouse lines with Cre knocked-in (KI) to the c-kit locus
(c-kitCreKI)10–13. c-kitCreKI lines show that myocardial
c-kit-expressing (c-kitpos) cells only minimally, if not
negligibly, contribute CMs10–14. However, the very low
number of endogenous c-kitposCSC-generated CMs
detected in the c-kitCre mice, simply reﬂects the failure of
the c-kitCre-null allele produced by Cre insertion to
recombine the CSCs and to track their progeny together
with the severe defect in CSCs myogenesis produced by
the c-kit hemizygosity15–18.
Recently, the deleterious effects of excessive catechola-
mines have been linked to the development of Takotsubo
syndrome, a stress-related form of acute severe, generally
transient, left ventricular (LV) dysfunction19. In rats and
mice, a single excessive dose injection (subcutaneous
(s.c.)) of the synthetic catecholamine, isoproterenol (ISO),
causes CM death20,21, which leads to the development of
acute HF, fully reversible by 28 days. Using this acute ISO-
damage model, by means of several genetic tests and
selective cell ablation/repopulation experiments, we pro-
vided the proof-of-concept evidence that resident CSCs
are necessary and sufﬁcient for the regeneration and
repair of myocardial damage21.
In contrast to our data, Wallner et al.22 reported that
ISO caused minimal myocardial necrosis, which recov-
ered without any meaningful contribution of “c-Kit
(+)-CSC-derived CM regeneration.” These results
obtained using the c-kitCreKI mutant mice10,22 have raised
further scepticism about the role of CSCs in the
adult heart.
Here we show that c-kit haploinsufﬁciency in c-kitCre KI
mice impairs the endogenous cardioregenerative response
after ISO affecting CSC activation and CM replacement.
Repopulation of c-kit haploinsufﬁcient myocardial tissue
with wild-type CSCs, as well c-kit gene deﬁcit correction
of haploinsufﬁcient CSCs, restores CM replacement and
cardiac function after ISO. Thus, these data show that
adult cardiomyogenesis depends on a diploid level of c-kit
in CSCs.
Materials and methods
Animals
All animal experimental procedures were approved by
Magna Graecia Institutional Review Boards on Animal
Use and Welfare and performed according to the Guide
for the Care and Use of Laboratory Animals from direc-
tive 2010/63/EU of the European Parliament. All animals
received human care and all efforts were made to mini-
mize animal suffering.
Mice were housed under controlled conditions of 25 °C,
50% relative humidity, and a 12 h light (6:00–18:00 h) and
12 h dark cycle, with water and food available ad libitum,
except for tamoxifen (TAM) diet described below. Mice
were anaesthetised by intraperitoneal (i.p.) injection of
ketamine (100mg/Kg) and xylazine (5mg/Kg) or inhaled
isoﬂurane (isoﬂurane 1.5% oxygen 98.5%, Iso-Vet,
Healthcare). As wild-type animals, C57BL/6J mice were
used (Jackson Labs, stock number 000664). c-kitCreGFPnls/+
and c-kitMCM/+ were provided by Dr. Jeffrey D. Molkentin
(Cincinnati Children’s Hospital Medical Center, Cincin-
nati, OH)10. Heterozygous c-kitCreGFPnls mice (abbreviated
as c-kitCre/+) were crossed with homozygous B6.Cg-Gt
(ROSA)26Sortm9(CAG-tdTomato)Hze/J reporter mice (abbre-
viated as R26ﬂoxed-stop-dTomato or R26dT, Jackson Labs,
stock number 007909), to generate double heterozygous
animals (abbreviated as c-kitCre/+:R26dT/+) for experi-
mental purposes. Heterozygous R26dT/+ mice were used
as controls.
To assess CM replenishment by CSCs after ISO, Tg
(Myh6-Cre/Esr1)1Jmk/J male mice (abbreviated as Tg-
myh6MCM, Jackson Labs, stock number 005650) were
crossed with homozygous Gt(ROSA)26Sortm4(ACTB-tdTo-
mato,-EGFP)Luo/J reporter mice (abbreviated as R26mT/mGor
R26mt-mg, Jackson Labs, stock number 007576), to gen-
erate double heterozygous animals. These double mutant
mice carry a TAM-inducible Cre Recombinase driven by
the cardiac α-myosin heavy chain (α-MHC or myh6)
promoter and a double ﬂuorescent (dT/mGFP) gene
reporter in the ROSA26 locus where, upon TAM-induced
Cre-dependent recombination, a membrane-bound
dimeric tomato (dT) is replaced by a membrane-bound
green ﬂuorescent protein (mGFP). Eight-week-old double
heterozygous Tg-myh6MCM:R26mT/mG male mice were
fed for 4 weeks with 40mg/Kg bw/d of TAM citrate chow
(400mg/Kg diet, ENVIGO, TD.130860) or alternatively
were i.p. injected in alternate days with (Z)-4-Hydro-
xytamoxifen (Sigma, H7904) at the dose of 40 mg/Kg for
2 weeks and then used 2 weeks later. For each experi-
mental procedure with TAM diet/injection, double het-
erozygous Tg-myh6MCM:R26mT/mG, Tg-myh6MCM and
R26mT/mG heterozygous littermates mice, were fed with
standard normal mouse diet as controls.
The ﬁnal n-value for each experimental group is spe-
ciﬁed in the relative ﬁgure legends.
ISO administration
ISO (Sigma-Aldrich #I6504; St. Louis, MO) was pre-
pared by dissolving a desired amount of powder in NaCl
0.9%. The solution obtained was protected from the
light and kept on ice until the injections. Before any
ISO/Saline injection, the body weight of animals was
determined, mice were anaesthetised using isoﬂurane
and baseline echocardiography obtained. Then, mice
were randomly divided in the different groups and on
awakening prepared to receive saline or ISO at dose of
200 mg/Kg or 400 mg/Kg. The solutions were injected s.
c. under the inter-scapular skin. All ISO injections were
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administered to male, 12-week-old mice of the speciﬁed
strains.
Echocardiography
Prior to echocardiography, mice were anaesthetised
with isoﬂurane. Unconscious mice were weighed and
secured in a supine position on a temperature-controlled
restraining board. Anesthesia was maintained with 1–2%
isoﬂurane in oxygen delivered through a nose cone. Four-
limb lead electrocardiograms (Vevo 3100 and MP150,
Biopac, Goleta, CA, USA) were simultaneously recorded.
All hair in the thoracic region was removed using a
depilatory agent and the area was cleaned with water.
Ultrasound gel was applied to the thoracic region to
improve sound wave transmission. All mice were main-
tained at heart rates > 400 b.p.m., while images were
recorded. Echocardiographic images were obtained with a
Vevo 3100 system (Visualsonics, Inc., Toronto, Canada)
equipped with a MX550D ultra-high frequency linear
array transducer (22–55MHz). The transducer was
positioned in a stationary stand perpendicular to the
mouse (in some cases, manual adaptations were needed
for optimal imaging). In brief, a frame rate of > 200 frames
per minute was maintained for all B-mode and M-mode
images. B-mode long-axis parasternal images were
recorded when optimal views of the aorta, papillary
muscle, and endocardium were visible. M-mode short-
axis images were recorded at the level of the papillary
muscles and the LV was bisected to obtain the optimal M-
mode selection. Conventional echocardiographic mea-
surements of the LV included ejection fraction (EF),
fractional shortening (FS), end-diastolic dimension, end-
systolic dimension, anterior and posterior wall thickness,
and mass were obtained. For long-axis B-mode mea-
surements, the endocardium was traced semi-
automatically beginning from the mitral valve and
excluding the papillary muscle. EF and FS were calculated
by software using standard computational methods.
Advanced cardiac analysis (regional and global cardiac
measurements) were assessed by speckle-tracking echo-
cardiography (Vevo LAB analysis software; VisualSonics).
Cardiac cycles were acquired digitally from the para-
sternal long-axis and mid-ventricular short-axis views for
the assessment of radial, circumferential, and longitudinal
systolic strain/velocity (in accordance with myocardial
ﬁbre orientation at varying levels of the LV wall) and
time-to-peak systolic strain/velocity. Images selected for
strain analysis had well-deﬁned endocardium and epi-
cardium borders and no substantial image artefacts.
Image analysis was performed according to the manu-
facturer’s instructions. The endocardium and epicardium
were traced semi-automatically using VevoStrain soft-
ware. The traces were manually adjusted to ensure ade-
quate tracking of endocardium and epicardium borders.
Velocity, displacement, strain, and strain rate were cal-
culated for radial and longitudinal planes. In long axis, the
basal anterior-septum, mid-anterior-septum, apical ante-
rior-septum, basal posterior wall, mid-posterior wall, and
apical posterior segments were deﬁned. In mid-
ventricular short axis, the anterior, anterior-septum,
inferior-septum, inferior, posterior, and anterior-lateral
segments were further delineated. Tissue contraction
patterns were expressed as negative strain values for
longitudinal and circumferential motion, and positive
values for radial strain. In each segment, peak systolic
strain (%) and time-to-peak systolic strain (ms) were
analysed. Global average peak values for circumferential
and longitudinal strain are reported.
The n-value for each experimental group is speciﬁed in
the relative ﬁgure legends.
Myocyte necrosis analysis
To assess CM necrosis, 12-week-old male mice were
used. Mice (strains are speciﬁed in the main text and
ﬁgure legends) received i.p. injection of 100 µg/100 µl of a
monoclonal antibody against cardiac myosin (MF-20, ID:
AB_2147781, DSHB) 2 h after ISO injection. Alternatively,
mice received i.p. injections of 50 µl/10 g of the body
weight of a 20mg/ml stock solution of Evan’s blue dye
(EBD, Sigma-Aldrich) dissolved in NaCl 0.9% admini-
strated 24 h before ISO/Saline injections. All animals were
sacriﬁed at 1 day after ISO/Saline injection and the heart
ﬁxed with 4% paraformaldehyde (PFA).
The n-value for each experimental group is speciﬁed in
the relative ﬁgure legends.
Cardiac troponin analysis
To assess the presence of myocyte necrosis induced by a
single dose of ISO, the levels of high-sensitive cardiac
Troponin T (cTnT) in the blood serum were analysed
1 day after ISO/Saline. Animals were anaesthetized
(ketamine 100 mg/Kg and xylazine 5 mg/Kg) and 1ml of
blood was taken from the orbital sinus inserting the tip of
a ﬁne-glass Pasteur pipette into the corner of the eye
underneath the eyeball, directing the tip at a 45° angle
towards the middle of the eye. The blood was collected in
a vacutainer (Vacuette Tube 3 ml K3E K3EDTA, #
454086). The threshold for cTnT positivity in mice was
established at the 99th percentile of cTnT values in blood
samples from 15 consecutive control mice, using a com-
mercially available and clinically validated blood cTnT kit.
The n-value for each experimental group is speciﬁed in
the relative ﬁgure legends.
BrdU and Edu incorporation in vivo
To detect in vivo cell proliferation after ISO adminis-
tration, 12-week-old male C57BL/6J mice were injected at
12 pm with saline or ISO at dose of 200 mg/Kg. Six hours
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later, mice received an i.p. injection of Bromodeoxyur-
idine (BrdU) or 5-Ethynyl-2´-deoxyuridine (EdU) at a
concentration of 50 mg/Kg in 100 µl of a 50% de-ionized
water and 50% dimethylsulfoxide (DMSO) solution (Brdu,
Sigma B9285; EdU, Life Technologies E10187). The
morning after, all mice were anaesthetized using iso-
ﬂurane and implanted subcutaneously (between the two
scapulae) with mini-osmotic pumps (ALZET)21 to sys-
temically release BrdU or EdU (50 mg/Kg/Day both) for 7
or 28 days prepared by dissolving the powders in 50% de-
ionized water and 50% DMSO. Mice from each group
were sacriﬁed at 28 days after ISO/Saline administration
and the hearts were ﬁxed in formalin for immunohis-
tochemistry analysis.
To assess the regenerative potential of c-kitCre mice,
heterozygous c-kitCre/+ mice, heterozygous R26dT/+ mice,
and double heterozygous c-kitCre/+:R26dT/+ mice were
treated with ISO/Saline and implanted for 28 days with
BrdU pumps as described above. In addition, ~35% of
available male c-kitCre/+:R26dT/+ exhibited spontaneous
alterations of cardiac function at baseline pre-ISO injec-
tions and had to be excluded. To assess the effects of ISO
administration on activation of quiescent resident CSCs,
R26dT/+ and c-kitCre/+:R26dT/+ mice were divided in
saline-injected and ISO-injected groups as above. BrdU, at
a concentration of 50 mg/Kg/Day, was i.p. administered
in vivo for 3 days in adult mice every 12 h before sacriﬁce.
The mice were sacriﬁed at 1 day or 3 days after ISO
injection and hearts were dissociated to obtain a myocyte-
depleted cardiac cell preparation for ﬂuorescence-
activated cell sorting (FACS) analysis as described18,21,23.
To further assess the cardiac generation process, myo-
cardial nuclei were isolated 28 days after ISO or Saline
from mouse hearts continuously labelled with BrdU and
evaluated by FACS analysis for BrdU detection as pre-
viously reported24.
The n-value for each experimental group is speciﬁed in
the relative ﬁgure legends.
ISO+ 5-FU-induced cardiomyopathy
Chronic HF was induced in 12-week-old male C57BL/6J
mice, in heterozygous Tg-myh6MCM mice, and in
Tg-myh6MCM: R26mT-mG/+ double heterozygous mice by
a subcutaneous single-dose administration of ISO
200mg/Kg followed at 72 h by systemic administration of
5-Fluorouracil (5-FU,15 mg/Kg/daily) for 25 days through
subcutaneously implantation of mini-osmotic pumps.
Before pumps implantation the mice were anaesthetized
using isoﬂurane. Twenty-eight days after ISO injection, 5-
FU-realizing mini-pumps were removed. Tg-myh6MCM:
R26mT-mG/+ double heterozygous mice were killed and
the hearts were ﬁxed in 4% PFA for immunohistochem-
istry analysis. C57BL/6J mice were randomly divided to
receive tail vein CSCs/Saline injections as indicated. The
animals were sacriﬁed 28 days after CSCs/Saline injec-
tions and the hearts were ﬁxed in formalin for immuno-
histochemistry analysis or dissociated to obtain a cardiac
cell preparation for FACS analysis.
The n-value for each experimental group is speciﬁed in
the relative ﬁgure legends.
Myocyte-depleted cardiac cell isolation
CSCs were isolated from the relative adult mouse hearts
by enzymatic dissociation using a Langerdoff-modiﬁed
apparatus23 or using gentle MACS Dissociator (Miltenyi
Biotec)17,18. Brieﬂy, for the Langerdoff-modiﬁed appara-
tus, the heart was excised, the aorta cannulated, and hung
on a retrograde perfusion system. Heart was perfused with
collagenase type II dissolved HEPES-MEM (Sigma)
(Worthington) at 37 °C with 85% O2 and 15% N2, then the
heart was removed from the apparatus, cut into small
pieces, and the fragments shaken in re-suspension med-
ium at 37 °C. CMs and myocyte-depleted small cardiac
cells were separated by centrifugation. For gentle MACS-
isolation, manufacturer instructions were followed to
obtain myocyte-depleted cardiac small cells for FACS
analysis. To obtain CSC-enriched CD45negCD31negc-
kitpos cells, the MACS technology was used with direct
CD45- and CD31-negative and then c-kit-positive speciﬁc
anti-mouse microbeads sorting (Miltenyi Biotec)17,18,23.
Cell cultures and transfection
Isolated CSC-enriched CD45negCD31negc-kitpos cardiac
cells were plated in gelatin-coated dishes in CSC growth
medium containing Dulbecco’s modiﬁed Eagle’s medium-
F12Ham’s (Gibco, Life Technologies) with insulin-
transferrin-selenium (1%, Life Technologies), epidermal
growth factor (ﬁnal medium concentration: 20 ng/ml,
Peprotech), basal ﬁbroblast growth factor (ﬁnal medium
concentration: 10 ng/ml, Peprotech), and leukemia inhi-
bitory factor (ﬁnal medium concentration: 10 ng/ml,
Miltenyi), and 1:1 ratio of Neurobasal medium (Gibco,
Life Technologies) containing 37mg of L-glutamine,
B27 supplement (2%, Life Technologies) and
N2 supplement (1%, Life Technologies),
penicillin–streptomycin (1%, Life Technologies), Fungi-
zone (0.1%, Life Technologies), and gentamicin (0.1%, Life
Technologies) sterilized through a 0.22 µm pore ﬁlter into
a sterile container, and store it at 4 °C for up to
3 weeks21,23. The CSC growth medium was supplemented
with 10% ESQ-FBS (Life Technologies). Cells were
maintained at 37 °C in ambient O2 (21%) and 5% CO2.
Media were replenished every 48 h and cells were pas-
saged at a 1:4 ratio. dT-wtCSCs, dT-WCreCSCs, and YFP-
wtCSCs (also CSCYFP) clones were respectively obtained
from R26mT-mG/+, c-kitCreER(T2)/+:R26mT-mG/+18, and
R26stopYFP21 mice by depositing through serial dilution a
single CD45negCD31negc-kitpos isolated cardiac cells from
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mice heart into 96-well gelatin-coated Terasaki plates.
Individual clones were identiﬁed, expanded, and grown in
CSC growth medium. Cell growth of freshly isolated (P1)
WCreCSCs vs. wtCSCs was assessed by plating 1 × 104
cells in gelatin-coated dishes in CSC growth medium.
Cells were counted every 24 h until day 4. Cardiac ﬁbro-
blasts (cFBs) were isolated from R26stopYFP mice as pre-
viously described21. The Cre-reporter gene, Yellow
ﬂuorescent protein (YFP), was switched on through
transduction of R26stopYFP CSCs and cFBs with an Adeno-
CMV-Cre in vitro (Santa Cruz Biotechnology) as per the
manufacturer’s instructions. Stealth RNAi c-KIT small
interfering RNA (Thermo Fisher Scientiﬁc) was trans-
fected in CSCYFP using Lipofectamine RNAiMAX
Transfection Reagent (Thermo Fisher Scientiﬁc) and
efﬁcient KIT knockdown was veriﬁed by reverse
transcriptase-PCR as per the manufacturer’s instructions.
The n-value of biological replicates is speciﬁed in the
relative ﬁgure legends.
BAC c-kit vector generation and transfection in WCreCSCs
A puriﬁed bacterial artiﬁcial chromosome (BAC), BACc-kit
DNA was generated and then transfected in a
dT-WCreCSCs clone obtained from c-kitCreER(T2)/+:R26mT-
mG/+ mice as previously described18,25. A single-cell-
derived sub-clone of dT-WCreCSCs containing a single
BACc-kit copy was obtained as previously described and
used for the in vivo cell transplantation experiments18.
MethoCult assay in vitro
Colony Forming Unit (CFU) formation from cloned
wtCSCs vs. WCreCSCs was assessed by plating relative
cells in 1.2 ml of MethoCult medium (STEMCELL
Technologies, Vancouver, Canada) (1% methylcellulose in
CSC growth medium). Colonies were counted at 14 days
after plating. The n-value for the biological replicates is
speciﬁed in the relative ﬁgure legends.
Bone marrow cell isolation
Bone marrow (BM) cells were isolated from mice by
ﬂushing both femurs and tibias with phosphate-buffered
saline (w/o Ca, w/o Mg) using a 26-gauge needle syringe.
Cells were pelleted, washed, and re-suspended for FACS
analysis. For BM lineage-negative FACS analysis, a Line-
age Negative Depletion Kit was used (Miltenyi Biotec).
The n-value of biological replicates is speciﬁed in the
relative ﬁgure legends.
Tissue harvesting, histology, and immunohistochemistry
For immunohistochemistry analysis, the abdominal
aorta was cannulated and the heart arrested in diastole
using cadmium chloride/potassium solution. The animals
were perfused through the cannulated aorta and ﬁxed
with 10% buffered formalin or with 4% PFA. The hearts
were cut into apical, mid, and basal regions, and the right
and left atria. After being weighed, the LV was sectioned
embedded in parafﬁn or in Optimal Cutting Temperature
Compound. Tissues were cut in 5 µm or 10 µm cross-
sections, respectively. Apoptotic cells on cross-sections
were detected using the primary antibody caspase-3
(1:100 dilution: Abcam) and horseradish peroxidase-
conjugated secondary antibody, and visualized by 3,3′-
Diaminobenzidine (DAB) substrate histochemistry. Sec-
tions were stained with hematoxylin and eosin (H&E)
following standard procedures. Formalin-ﬁxed sections
were stained with Masson’s Trichome (PolySciences, Inc.)
for bioquantiﬁcation of ﬁbrosis26. CM cross-sectional area
was measured through immunostaining with Wheat
Germ Agglutinin (WGA) Alexa Fluor 647 conjugate
(1:200 dilution; Invitrogen) and digital analysis of acquired
cardiac cross-section images (Leica, 1128 LAS AF Soft-
ware). CM diameter was measured across the nucleus on
three transverse sections (~500 myocytes/animal were
sampled). For immunostaining and BrdU detection,
antigen retrieval was achieved using Target Retrieval
Solution, Citrate pH 6 (DAKO). For EdU detection, the
Click-iT EdU Imaging Kit (Life Technologies) was used.
The following primary antibodies were used: anti-BrdU
(1:50 dilution; Sigma), anti-EdU (1:500, Click-iT EdU
Imaging Kit, Life Technologies), monoclonal antibody
against cardiac myosin (MF-20, ID: AB_2147781, DSHB),
anti-Actinin (1:50 dilution; Santa Cruz), anti-Cardiac
Troponin I (1:50 dilution; Abcam), anti-GFP (for YFP
detection) (1:50 dilution; Rockland), anti-RFP (for dTo-
mato detection) (1:50 dilution; Rockland), anti-c-kit (1:50
dilution; R&D Systems), and anti-pericentriolar material 1
(PCM-1) (1:200 dilution; Atlas Antibodies). The primary
antibody was revealed by respective anti-mouse IgG, anti-
rabbit IgG, or anti-goat IgG secondary antibody (1:100
dilution; Jackson Immunoresearch). The nuclei were
counterstained with the DNA binding dye, DAPI (4, 6-
diamidino-2-phenylindole, Sigma) at 1 µg/ml. BrdU and
EdU ﬂuorescence quantiﬁcation has been obtained
through manual counting of respective histologic samples
and the number of BrdUpos or EdUpos CMs was expressed
as a percent fraction of the total CM nuclei17,21. To
evaluate the CM progeny of the YFPpos or dTomatopos
CSCs in vivo, the number of double positive YFPpos/
actininpos (or YFPpos/cTnIpos) and dTomatopos/actininpos
(or dTomatopos/cTnIpos) CMs were counted in cardiac
cross-sections derived from mice for each power ﬁeld
using a ×63 objective for a total of 20 ﬁelds17,21. The
number of c-kitposCD45negCD31neg cells in all experi-
mental group was expressed per mm2. The number of
YFPpos or dTomatopos CMs in all experimental group was
expressed as a percent fraction of the total CM number
per mm2. The number of necrotic/dead MF-20pos and
EBDpos (the latter ﬂuoresces in red) CMs was manually
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counted in cardiac cross-sections for each power ﬁeld
using a ×63 objective for a total of 20 ﬁelds17,21, and the
number of MF-20pos and EBDpos CMs was expressed as a
percent fraction of the total CM number per mm2. All
stainings were acquired and analysed using confocal
microscopy (LEICA TCS SP5 and SP8).
Flow cytometry
Cell analysis on total freshly isolated c-kitpos cardiac
cells, freshly isolated CD45negCD31negc-kitpos CSCs, and
BM cells was performed using a FACSCanto II (BD
Biosciences) or a BD FACSAria™ III (BD Biosciences).
FlowJo software (Treestar) was used to identify the per-
centage of cells expressing the different cell surface
markers of interest. Voltages for cytometry acquisition
were determined using single stain. Speciﬁc antibodies
used are shown in Supplementary Table 1 (bottom of this
ﬁle). Appropriate labelled isotype controls were used to
deﬁne the speciﬁc gates. The n-value for each group is
speciﬁed in the relative ﬁgure legends.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
version 6.00 for Macintosh (GraphPad Software). Quan-
titative data are reported as mean ± SD and binary data by
counts. Signiﬁcance between two groups was determined
by Student’s t-test or paired t-test as appropriate. For
comparison between multiple groups, analysis of variance
was used. A P-value < 0.05 was considered signiﬁcant.
Tukey’s post-hoc method was used to locate the differ-
ences. In these cases, the Type 1 error (α= 0.05) was
corrected by the number of statistical comparisons per-
formed. For the in vitro cell and molecular biology
experiments, the Kruskal–Wallis test (for multiple‐group
comparison) and the Mann–Whitney U-test (for com-
parison between two groups) were also performed.
Results
Acute ISO overdose causes CM necrosis and apoptosis in a
dose-dependent manner in the LV sub-endocardial apex
ISO at 200mg/Kg21 (n= 14) or at 400mg/Kg (lethal
dose in the study by Wallner et al.22) (n= 14) caused
diffuse CM necrosis in 12-week-old C57BL/6J male mice
as revealed by in vivo myosin antibody labelling27 1 day
after ISO injection (Fig. 1). Myosin-labelled CMs showed
clear morphologic features of necrosis with loss of cell
membrane integrity and architectural disarray (Fig. 1).
The damage was distributed in an intensity/density pro-
gressive gradient from epicardium to sub-endocardium
and from base to apex (Fig. 1a–c). CM death mostly
concentrated to the sub-endocardial apex where myosin-
labelled necrotic CMs reached up to ~8% and ~12% after
ISO 200 or 400mg/Kg ISO, respectively (Fig. 1a–d). Only
very rare (~0,001% of total) myosin-labelled CMs were
detected in the saline-injected mice; however, these anti-
myosin-labelled CMs were always normally shaped and
without additional signs of necrosis (Fig. 1e). Increased
cTnT blood levels independently conﬁrmed CM necrosis
directly proportional to the ISO dose (Fig. 1f). The normal
cTnT values baseline was established at <0.01 ng/ml in 15
consecutive control mice. Blood cTnT levels increased to
0.25 ± 0.14 and 0.58 ± 0.21 ng/ml 1 day after 200 or
400mg/Kg ISO, respectively (Fig. 1f).
The assessment of EBD28-positive CMs at 1 day after
ISO closely reproduced the CM necrosis data obtained
with myosin antibody labelling (Supplementary Fig. 1). In
addition, CM necrotic death after ISO was also evident by
H&E histochemistry (Supplementary Fig. 1B). Finally, ISO
exposure caused apoptotic CM death in a dose-dependent
manner as identiﬁed by caspase-3 labelling (Supplemen-
tary Fig. 1C).
High dose of ISO transiently impairs LV regional
performance
To assess the functional consequences of ISO-induced
CM damage and death, additional mice were injected with
either 200 mg/Kg or 400mg/Kg ISO and analysed by
echocardiography (ECHO). Saline-injected mice were
used as sham controls. Two mice in the 200mg/Kg and 3
mice in the 400mg/Kg ISO group died during the
ﬁrst week.
Only ISO at 400mg/Kg signiﬁcantly decreased LV EF
and FS after 1 day compared with baseline. There was a
nonsigniﬁcant decrease in EF in mice treated with
200mg/Kg ISO (Fig. 2a–d, Supplementary Fig. 2, and
Supplementary Table 2). However, despite a preserved EF
(Fig. 2d and Supplementary Table 2), ISO 200mg/Kg
mice showed a signiﬁcant decrease in FS at 1 day (Fig. 2c
and Supplementary Table 2). EF 2 days after 200mg/Kg
ISO showed a signiﬁcant depression compared with
baseline. The latter could be explained by the evidence
that a detectable reduction in EF is often a late phe-
nomenon29 (Fig. 2d and Supplementary Table 2). At the
same time point, LV function was also consistently
depressed in mice treated with 400mg/Kg ISO (Fig. 2a–d
and Supplementary Table 2). Segmental dysfunction was
more prominent at mid-apical regions (see below) and
evident apical ballooning was present in approximately a
third of the injected mice.
Diastolic dysfunction was evident at 1 and 2 days after
ISO, both at 200 or 400mg/Kg, when compared with base
(Fig. 2e, f, Supplementary Fig. 2, and Supplementary Table 2).
Speciﬁcally, the diastolic function shows that the E’-value
decreases (indicating a reduction of LV longitudinal
myocardial relaxation) (Fig. 2f and Supplementary Table 2),
whereas E/E’ (the ratio of transmitral Doppler early-ﬁlling
velocity to tissue Doppler early-diastolic mitral annular
velocity, an index of LV end-diastolic ﬁlling pressure)
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Fig. 1 ISO acutely causes cardiomyocyte necrosis mainly targeting the sub-endocardial apex. a The fraction of necrotic cardiomyocytes (CM)
was signiﬁcantly increased in a dose-dependent manner at 1 day after ISO (200 and 400 mg/Kg) with higher frequency in the Apex sub-endocardium.
n= 7 per group; *p < 0.05 vs. saline; #p < 0.05 vs. Epi; †p < 0.05 vs. Mid; ‡p < 0.05 vs. 200 mg/Kg (one-way ANOVA analysis with Tukey’s multiple
comparison test). b Representative images of necrotic CMs labelled in vivo with anti-myosin antibody (green) showing higher damage in the sub-
endocardium when compared with myocardium and epicardium. c, d Representative images of necrotic CMs labelled in vivo with anti-myosin
antibody (green) showing ISO dose-dependent higher damage in the apex when compared with mid and base in LV regions 1 day after ISO 200
(c) or 400 (d) mg/Kg, respectively. e Representative image of a non-necrotic anti-myosin antibody (green)-labelled normal cardiomyocyte. f Plasma
cTnI was signiﬁcantly elevated in a dose-dependent manner at 1 day after ISO. hs-TnT= high-sensitive cardiac Troponin T. n= 7 per group; *P < 0.05
vs. Saline; #p < 0.05 vs. 200 mg/Kg (one-way ANOVA analysis with Tukey’s multiple comparison test). Scale bars= 50 µm except for b left panel=
300 µm. All data are mean ± SD
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signiﬁcantly increases (Fig. 2f and Supplementary Table
2). All these parameters had returned to baseline
at 28 days after ISO (Fig. 2a–f and Supplementary
Table 2).
Global strain analysis29 was able to detect subtle
changes in cardiac performance earlier than conven-
tional standard echocardiographic measures in 200mg/ Kg
ISO-treated mice (Fig. 2g, h and Supplementary Table 2).
ISO, both at 200 and 400mg/Kg, signiﬁcantly decreased
the value of global longitudinal strain at 1 day compared
with baseline. Global longitudinal strain remained con-
sistently depressed at 2 days (Fig. 2g and Supplementary
Table 2). Interestingly, only in mice treated with 400mg/
Kg ISO, global circumferential strain was signiﬁcantly
Fig. 2 (See legend on next page.)
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decreased at 2 days compared with baseline (Fig. 2h and
Supplementary Table 2). All strain values were
normalized at 28 days (Fig. 2g, h and Supplementary
Table 2).
Finally, regional speckle-tracking strain analysis
throughout four segments at 1 day after ISO 200mg/Kg
showed an increase in time-to peak value in apical seg-
ments (even in mice with preserved EF) when compared
with the uninjured segments (Fig. 2i and Supplementary
Table 2). Also, segments analysis of wall motion
abnormalities and wall synchronicity detected early car-
diac damage (Fig. 2i and Supplementary Table 2).
CM loss by a single high dose of ISO triggers their
replacement with new CMs by the CSCs and not through
division of pre-existing CMs
We assessed new CM formation 28 days after ISO by
comparing head-to-head BrdU vs. EdU continuous
labelling (through mini-pump implants releasing BrdU
or EdU 50 mg/Kg daily) for 7 or 28 days after ISO
(200 mg/Kg). We detected new CM formation both in
EdU- and BrdU-continuously labelled mice, which was
more intense and mainly localized to the sub-
endocardial apex (Fig. 3a). The fraction of BrdUpos and
EdUpos CMs was ~7% and ~3% of the CMs in the sub-
endocardial apical layer at 28 days, respectively, com-
pared with ~0,1% in saline-treated mice. Newly formed
CMs were signiﬁcantly less abundant in the mid- and
basal myocardial regions (Fig. 3b), in agreement with
less CM damage in these areas (Fig. 1). Also, BrdUpos
and EdUpos CMs were signiﬁcantly less abundant with
only 7 days compared with 28 days continuous thymi-
dine analogues’ administration after ISO (Fig. 3b). In all
cases, however, EdU-labelled less (< 50%) newly formed
CMs than BrdU either after 7-days or 28-days of con-
tinuous administration (Fig. 3b).
CM nuclei-speciﬁc identiﬁcation with PCM-1 anti-
body24 show that the number of BrdUposPCM-1poscTnIpos
CMs (5.6 ± 1%, Fig. 3c) 28 days after ISO in the sub-
endocardial layer of the apical section was practically
undistinguishable from the number of BrdUpos CM nuclei
identiﬁed and counted by morphological features
(Fig. 3b). Isolated CM nuclei were evaluated for PCM-1
and BrdU detection by FACS (Fig. 3d), allowing for
unambiguous direct evaluation of BrdUpos CMs. These
data well reproduced the immunohistochemistry data in
Fig. 3b.
We also analysed new CM formation using double
transgenic myh6-mER-Cre-mER//R26RmT-mG mice
(abbreviated as Tg-myh6MCM:R26mT-mG mice). Dilution
of the GFPposCMs/dTomatoposCMs ratio with an increase
of dTomatopos CMs after ISO (Supplementary Fig. 3) in
these mice show that the new CM formation was not due
to division of pre-existing CMs. Also, these data implicate
that increased number of dTomatopos CMs had to have
arisen from non-myocyte myogenic progenitor/precursor
cells30–32.
c-kit receptor hemizygosity impairs the adult cardiac
regenerative response after ISO
Wallner et al.22 used a constitutive and TAM-inducible
c-kitCre KI mice10 to track the fate of the “c-kit+cells” and
did not ﬁnd any increase in “c-kit+cell-derived CMs” after
ISO. Their work was based on the assumption that the c-
kitCreKI allele in their mouse models efﬁciently recom-
bines the marker gene in the c-kitposCSCs. However, we
have recently shown that all the c-kitCre KI alleles so far
used10–12 are very inefﬁcient in driving recombination of
the marker gene in many c-kit+cells, particularly the
CSCs18. This is so because the efﬁciency of Cre recom-
bination in these mice is directly proportional to the level
of c-kit expression in the cell15,16, which is high in mast
(see ﬁgure on previous page)
Fig. 2 Isoproterenol transiently impairs cardiac function. a Representative M-mode tracing at Base, 1 day and 2 days after a single s.c. injection of
Isoproterenol (ISO) at 200 or 400 mg/Kg. b–d Cumulative data of cardiac dimensions and function at the different time points. LVESD= left
ventricular end-systolic diameter (b), FS= fractional shortening (c), and EF= ejection fraction (d). b, d *p < 0.05 vs. Base, 1d and 28d in ISO 200mg;
*p < 0.05 vs. Base and 28d in ISO 400mg (one-way ANOVA analysis with Tukey’s multiple comparison test). c *p < 0.05 vs. Base and 28d in ISO 200mg
and *p < 0.05 vs. Base and 28d in ISO 400mg (one-way ANOVA analysis with Tukey’s multiple comparison test). e Representative pulsed wave
Doppler Mitral Velocity tracing (PW MV, left) and cumulative transmitral Doppler early ﬁlling velocity (MV E data, right) at Base, 1d and 2d after a single
s.c. injection of ISO at 200 or 400mg/Kg. *p < 0.05 vs. Base, 1d, and 28d in ISO 400mg (one-way ANOVA analysis with Tukey’s multiple comparison
test). f Representative pulsed wave tissue Doppler imaging velocity tracing (PW TDI, left) and cumulative early diastolic mitral annular velocity value
(E’, mid) and E/E’ ratio (right) data at Base, 1d and 2d after a single s.c. injection of ISO at 200 or 400 mg/Kg. *p < 0.05 vs. Base and 28d in ISO 200mg
and *p < 0.05 vs. Base and 28d in ISO 400mg (one-way ANOVA analysis with Tukey’s multiple comparison test). g, h Cumulative data of global
longitudinal and circumferential strain (GLS and GCS, respectively) at the different time points at Base, 1d and 2d after a single s.c. injection of ISO at
200 or 400mg/Kg. g *p < 0.05 vs. Base and 28d in ISO 200mg and *p < 0.05 vs. Base and 28d in ISO 400mg (one-way ANOVA analysis with Tukey’s
multiple comparison test). h *p < 0.05 vs. Base, 1d, and 28d in ISO 400mg (one-way ANOVA analysis with Tukey’s multiple comparison test).
i Representative images of regional speckle-tracking strain analysis throughout four segments (apical, anterior and inferior segments wall, and mid-
anterior and inferior wall) at Base, 1d and 2d after a single s.c. injection of ISO at 200mg/Kg. n= 15 (ISO 200mg/Kg, BASE, 1d, and 2d); n= 13 (ISO
200mg/Kg, 28d); n= 15 (ISO 400mg/Kg, BASE and 1d); n= 12 (ISO 400mg/Kg, 2d, and 28d). All data are mean ± SD
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Fig. 3 (See legend on next page.)
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and endothelial (progenitor) cells but many fold lower in
the CSCs18. Both constitutive c-kitCreGFPnls/+ and TAM-
inducible c-kitmERCremER/+ (c-kitMCM/+) mouse lines have
a null c-kit allele and thus they are phenotypically similar
to W/+mice33–35, show the typical white spotting in the
coat (Fig. 4a), have a 50% decrease of c-kit expression18,
and are incompatible with late fetal/early post-natal life in
homozygosis10,12. The W-mutation phenotype of the
c-kitCreKIs mice is conﬁrmed by the size of a prototypical
c-kit-dependent organ, such as the testis, from 2-month-
old c-kitCre mice that shows a signiﬁcant size reduction
(Fig. 4b), which, in part, explains the low fertility of the c-
kitCreKI lines. Most relevant, the c-kit haploinsufﬁciency
severely impairs the c-kitposCSCs growth, clonal expan-
sion (Fig. 4c, d), and myogenic differentiation18. In addi-
tion, in constitutive c-kitCreGFPnls mice, the GFP nuclear
expression (GFPnls) has a surprisingly low coincidence
with c-kit expression. Only ~25% of the c-kitpos BM cells
expressed detectable GFPnls (Fig. 4e), while the vast
majority of c-kitpos cardiac cells were GFPnls negative by
FACS and/or tissue immunohistochemistry (Fig. 4f).
ISO (200mg/Kg) was injected into 12-week-old male
double mutant mice, c-kitCreGFPnls: R26ﬂoxed-stop-dTomato/+
and in control R26ﬂoxed-stop-dTomato/+ littermates36, all
implanted with subcutaneous mini-pumps to release
BrdU for 28 days. In the Cre-constitutive double trans-
genic mice, all the cells, which have undergone Cre-
dependent recombination (in theory, all cells expressing
c-kit) should become dTomatopos. However, at baseline
before ISO, ~70% of Lineage-committed (CD45pos/
CD31pos) c-kitpos cardiac cells (mainly blood and endo-
thelial lineage-derived cells) are dTomatopos (Fig. 4g). On
the other hand, only 10 ± 3% of the Linneg(CD45neg/
CD31neg) c-kitpos cells (which include all the CSCs) are
dTomatopos (Fig. 4g). Thus, this system is very inefﬁcient
and nor reliable to track the resident CSCs and their
progeny15,16,18.
In a separate experiment with c-kitCreGFPnls/+ (abbreviated
also as c-kitCRE/+) mice, c-kitCre hearts show a similar CM
necrosis as the control hearts from wt c-kit+/+ littermates at
1 day after ISO (Fig. 5a, b). At 3 days after ISO, control
R26ﬂoxed-stop-dTomato/+ (abbreviated also as R26dT/+) hearts
show a signiﬁcant increase in the number of resident
CD45negCD31negc-kitposCSCs, whereas the c-kitCRE/+:
R26dT/+ hearts only show a minimal increase when com-
pared with the respective uninjured controls (Fig. 5c). In the
uninjured control R26dT/+ mice, the majority of freshly
isolated CD45negCD31negc-kitpos/lowCSCs (a representative
scheme of their identiﬁcation and isolation is presented in
Fig. 5d) are quiescent with only 5 ± 1% in the cell cycle, as
measured by BrdU incorporation (Fig. 5e). In these mice,
ISO injury caused a rapid and signiﬁcant egress of the CSC
pool from the quiescent state with 80 ± 8% of activated
BrdUposCSCs at 3 days (Fig. 5e). In addition, transient
amplifying and myogenic-committed c-kitposGata-4pos car-
diac progenitors signiﬁcantly increased after ISO compared
with vehicle-treated mice (Fig. 5f). In contrast, when com-
pared with control R26dT/+ mice, both the percentage of
BrdUposCSCs and myogenic-committed c-kitposGatapos
cardiac progenitors were much lower in c-kitCRE/+:R26dT/+
mice after ISO (Fig. 5e, f).
At 28 days after ISO, we detected only a slight increase
of c-kitpos cell-derived dTomatoposCMs (0.55 ± 0.07% vs.
0.21 ± 0.04%, p < 0.05) in the sub-endocardial apex of ISO-
injured vs. saline-injected c-kitCRE/+:R26dT/+ mice
(Fig. 6a). The number of BrdUpos CMs was also sig-
niﬁcantly lower in the c-kitCRE/+:R26dT/+mice than in the
R26dT/+ control littermates (0.75 ± 0.17% vs. 6.52 ± 1.04%,
p < 0.05) (Fig. 6b). The severe deﬁcit of CM regeneration
in c-kitCRE/+:R26dT/+ mice was accompanied by hyper-
trophy of the surviving pre-existing CMs, which was
absent in R26dT/+control mice (Fig. 6c). Also, although
the hearts of R26dT/+ control mice at 28 days after ISO
did not show evidence of ﬁbrosis, there was multiple areas
(see ﬁgure on previous page)
Fig. 3 Cardiomyocyte Replenishment after ISO-induced CM loss. a Representative confocal microscopy images of BrdU (left) and EdU (middle)
incorporation in the apical endocardium 28 days after ISO in wt C57BL/6J mice implanted with subcutaneous mini-pumps to systemically release
BrdU or EdU for 28 days. Right, representative confocal microscopy of BrdU incorporation from epicardium to endocardium of the LV Apex 28 days
after ISO in wt mice implanted with subcutaneous mini-pumps to systemically release BrdU for 28 days. It is evident the intensity gradient of BrdU
incorporation from the epicardium to the endocardium. Scale bar= 50 μm. b Number of newly generated BrdUpos or EdUpos CMs at 7 and 28 days in
saline or ISO-treated wt mice implanted with subcutaneous mini-pumps to systemically release EDU or BrdU for 7 or 28 days, respectively. n= 7 per
group, *p < 0.05 vs. Saline, #p < 0.05 vs. Epi, §p < 0.05 vs. Myo, and †p < 0.05 vs. EdU (one-way ANOVA analysis with Tukey’s multiple comparison test).
c Representative reconstruction of three overlapping confocal microscopy images (left) and a high magniﬁcation ﬁeld (×3 zoom from a ×63
microscopy objective, right) showing newly formed cardiomyocytes (arrowheads) whose nuclei are unambiguously identiﬁed by PCM-1 (white
ﬂuorescence) while being BrdU-positive (green) 28 days after ISO injury in the apical sub-endocardium. DAPI (Blue) depicts cell nuclei. d Cardiac
nuclei are identiﬁed by FACS analysis based on DAPI labelling (left panel). Fluorescent gating allows the separation of cardiomyocyte nuclei (PCM-1-
positive) and non-cardiomyocyte (PCM-1-negative) nuclei in cardiac nuclei preparations isolated from digested heart tissue (left-mid panel).
Representative plots show the number of BrdU-labelled cardiomyocyte nuclei (gated on PCM-1-positive nuclei) 28 after saline (right-mid panel) or
Isoproterenol (ISO, right panel) injection. It should be noted that the number of BrdUpos cardiomyocyte nuclei should be corrected when
extrapolating it to number of cardiomyocytes considering that by the vast majority of adult cardiomyocytes in the adult murine hearts are
binucleated. Scale bars= 50 µm. All data are mean ± SD
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of ﬁbrosis in the sub-endocardial apex of the c-kitCRE/+:
R26dT/+ mice, in agreement with the decreased CM
replacement (Fig. 6d). Twenty-eight days after ISO, the
lack of robust CM regeneration was accompanied by per-
sistence of LV functional impairment in c-kitCRE/+:R26dT/+,
which was absent in R26dT/+ control mice (Fig. 6e).
Fig. 4 (See legend on next page.)
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c-kit hemizygosity supresses CSC myogenicity and
regenerative potential
We tested whether transplantation of exogenous
wtCSCs would rescue the defective cardioregenerative
phenotype of c-kitCreKI mice. To this end, c-kitmERCremER/+
mice (hereafter c-kitMCM/+ mice)10 were ISO-injured
(200 mg/Kg). Twelve hours later, they were administered
through the tail vein with saline or 4 × 105 each of either
wt YFP+ CSCs (CSCYFP) or wt YFP+ cFBs (cFBsYFP)
(Fig. 6f, g). To further assess c-kit gene function in CSC
regenerative potential in vivo, additional ISO-injured mice
were similarly transplanted with CSCYFP transfected with
a KITsiRNA knocking down c-kit expression (Supplemen-
tary Fig. 4). At 28 days after ISO, the transplanted exo-
genous wtCSCYFP had differentiated into new YFP+ CMs
in the sub-endocardial layer where they reached 4 ± 1% of
total CMs (Fig. 6g, i), which were clearly absent in cFBs
transplanted mice (Fig. 6f, i). c-kit knockdown sig-
niﬁcantly reduced wtCSC myogenic potential, as indeed
CSCYFP-KITKD did not generate signiﬁcant new CMs (Fig.
6h, i). New CM formation, derived from the transplanted
wtCSCYFP, prevented cardiac ﬁbrosis when compared
with the recipients of either cFBsYFP, CSCYFP-KITKD, or
saline (Fig. 6j). wt CSCYFP transplantation in c-kitMCM/+
mice also normalized cardiac function, whereas the saline-,
cFBs-, and CSCYFP-KITKD-injected mice remained in HF
(Fig. 6k).
CSC activation and ensuing CM formation depends on a
proper level of c-kit function
To devoid the hearts of functional resident CSCs, ISO
injury was followed by 5-FU treatment21. This model
invariably leads to HF in rats and mice21. 5-FU regime
ablated proliferating CSCs and resulted in a severe CSC
deﬁcit, absent CM replacement, continued CM loss,
hypertrophy of surviving CMs and dilated decompensated
cardiomyopathy (Supplementary Fig. 5A–F). The lack of
CSC-derived CM regeneration in ISO+ 5-FU cardio-
myopathy was conﬁrmed using double transgenic
Tg-myh6MCM:R26mT/mG mice after TAM treatment
(Supplementary Fig. 5G).
Next, we addressed whether the CSCs are sufﬁcient to
regenerate the cardiac tissue lost and to restore myo-
cardial function after ISO injury. If so, whether the CSC
regenerative properties are dependent on a normal
diploid c-kit level. We compared in vivo the regenerative
properties of cloned WCreCSCs (so called for the W
phenotype of the c-kitCRE mice) obtained from
c-kitCreER(T2)/+:R26mT-mG/+ mice (hereafter dT-WCre
CSCs) with cloned wtCSCs from R26mT-mG/+ litter-
mates (dT-wtCSCs). A total of 4 × 105 cloned cells of
each type (all of them the progeny of a single cell) were
transplanted through the systemic circulation by tail
vein injection, into 16-week-old syngeneic male C57BL/
6J mice with ISO+ 5-FU failing cardiomyopathy21
(Fig. 7a). Control ISO+ 5-FU mice were injected an
equal volume of saline. One month after treatment, all
saline-injected mice and those transplanted with dT-
WCreCSCs were still in overt cardiac failure (Fig. 7b,
Supplementary Fig. 6A). In contrast, those treated with
dT-wtCSCs had completely recovered from cardiac
dysfunction (Fig. 7b, Supplementary Fig. 6A). In addi-
tion, although the dT-wtCSCs reconstituted the host’s
myocardial c-kitposCSC pool previously ablated by the
ISO+ 5-FU regime, the dT-WCreCSCs did not and the
myocardium of the relative recipient animals was prac-
tically devoid of CSCs (Fig. 7c, d). Concordantly, dTo-
matopos newly formed CMs (6.08 ± 1.16%) were detected
(see ﬁgure on previous page)
Fig. 4 c-kitCre mice fail to label resident CSCs. a Photographs of representative adult c-kitMCM and c-kitCreGFPnls/+ mice showing the typical
W-mutation-determined piebald and white belly spot as compared with c-kit+/+ C57BL/6J mouse. b The testis from 2-month-old kitMCM and
c-kitCreGFPnls/+ show a signiﬁcant size reduction compared to c-kit+/+mice. c Cell growth curve of freshly isolated (P1) WCreCSCs vs. wtCSCs over 96 h.
n= 7 biological replicates, *p < 0.05 vs. wtCSCs (Kruskal–Wallis test). d Colony number of 100 cloned wtCSCs vs. WCreCSCs in Methocult. n= 7
biological replicates, *p < 0.05 vs. wtCSCs (Student’s t-test). On the right, representative light microscopy images of a colony from wtCSCs and
WCreCSCs, respectively. n= 6 plots biological replicates. Scale bars= 1000 µm. e GFP expression (from the c-kitCreGFPnls allele) in the
monocyte–lymphocyte gate of total bone marrow (BM) cells population and in total c-kitpos BM cells from 2-month-old c-kitCreGFPnls/+mice. Less than
25% of the total c-kitpos BM cells express GFP in c-kitCreGFPnls/+ mice. Concurrently, <35% of the lineage-negative (Linneg) c-kitpos BM cells (including
HSCs) express GFP in c-kitCreGFPnls/+ mice. f GFP expression (from the c-kitCreGFPnls allele) in cardiomyocyte-depleted cardiac cells (left) and in cardiac
c-kitpos cardiac cells (right) from 2-month-old c-kitCreGFPnls/+mice. Less than 10% of these cells express GFP. Right, confocal microscopy representative
images of cardiac cross-sections showing that GFP nuclear expression is expressed only in some (20 ± 3%) of the c-kit-expressing cardiac cells. Scale
bar= 20 µm. (e, f representative of n= 5 BM/Hearts). g Mice KI-ed within the ﬁrst exon of the c-kit locus to express Cre recombinase and GFP with a
nuclear localization sequence (eGFPnls) behind an internal ribosome entry site (IRES) (c-kitCreGFPnls or c-kitCre) were crossed with B6.129S6-Gt(ROSA)
26Sortm9(CAG-tdTomato)Hze/J (abbreviated as R26ﬂoxed-dTomato) Cre-reporter mice, which harbour a targeted mutation of the Gt(ROSA)26Sor locus
with a loxP-ﬂanked STOP cassette preventing transcription of a CAG promoter-driven red ﬂuorescent protein variant (tdTomato), which is expressed
following Cre-mediated recombination. Approximately 20% of total cardiac cells and ~60% of c-kitpos cardiac cells from these mice are dTomatopos.
Approximately 70% of lineage-committed endothelial/mast cell (CD45pos/CD31posc-kitpos) cardiac cells are recombined to express dTomato,
whereas <10% of the CSC-enriched CD45negCD31neg/c-kitpos were recombined to become dTomatopos (g representative of n= 5 hearts). All data
are mean ± SD
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in the mice injected with dT-wtCSCs (Fig. 7e), whereas
the dT-WCreCSCs minimally contributed dTomatopos
CMs (0.18 ± 0.08%) in the ISO+ 5-FU failing hearts
(Fig. 7e). None of these effects was due to differential
tissue-homing and engraftment of dT-wtCSCs and dT-
WCreCSCs, as similar fractional numbers of each were
detected in the myocardium 24 h after cell transplanta-
tion (Supplementary Fig. 6B).
Fig. 5 c-kitCre mice show a defective CSC activation after injury in vivo. a, b Necrotic cardiomyocytes (CM) (revealed either by myosin Ab in vivo
labelling in a and EBD incorporation in b) were similarly increased in wild-type c-kit+/+ and heterozygous c-kit+/Cre mice at 1 day after ISO (200) in
the Apex sub-endocardium. n= 5 mice per group, *p < 0.05 vs. saline (one-way ANOVA analysis with Tukey’s multiple comparison test). Scale bars
= 50 µm. c c-kitCreGFPnls:R26ﬂoxed-dTomato/+ (abbreviated as c-kitCre/+:R26dT/+) mice show a blunt increase of resident CD45negc-kitpos CSCs when
compared with control R26ﬂoxed-dTomato/+ (abbreviated hereafter as R26dT/+) mice 3 days after ISO. n= 5 mice per group; *p < 0.05 vs. Saline; #p < 0.05
vs. R26dT/+ mice (one-way ANOVA analysis with Tukey’s multiple comparison test). d Representative FACS detection and isolation of CSCs from
cardiomyocyte-depleted cardiac cell preparations. Left, representative gating strategy using isotype antibodies. Pre-sorting, ﬂow cytometry dot plots
show that the majority of total c-kitpos cardiac cells are CD45 or CD31 positive (red box), whereas only a minority are CD45 and CD31 negative (green
box). Post sorting, ﬂow cytometry dot plots show that CD45posCD31pos (linpos) cells are efﬁciently removed from cardiac cells by CD45−CD31 sorting
and CD45negCD31negc-kitpos-sorted cells uniformly express low levels of c-kit. e Flow cytometry dot plots (representative of n= 3) show BrdU
incorporation in CD45neg c-kitpos cardiac cells from saline and ISO-treated R26dT/+ and c-kitCre/+:R26dT/+mice. BrdU—35mg/Kg bid—was
intraperitoneally administered in vivo for 3 days in adult mice every 12 h before killing. f Flow cytometry dot plots (representative of n= 3) show the
fraction of myogenic-committed Gata-4pos CD45negc-kitpos CSCs isolated from saline and ISO-treated R26dT/+ and c-kitCre/+:R26dT/+ mice. All data are
mean ± SD
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The regenerative phenotype of WCreCSCs was further
tested in a competitive reconstitution assay by co-
injecting YFP-positive (YFPpos) wtCSCs (obtained from
R26stopYFP reporter mice21) and dT-WCreCSCs in a 1:3
ratio (a total of 4 × 105 cells injected) into mice with ISO
+5-FU cardiomyopathy. At 28 days, the YFPposwtCSC
+WCreCSC combination had partially reverted the car-
diac dysfunction and CSC pool in all the animals treated
(Fig. 7a–c and Supplementary Fig. 6A). However, in these
hearts—although the YFPposwtCSC were only 25% of the
CSCs transplanted—the Linnegc-kitposCSC pool was con-
stituted exclusively by YFPposwtCSCs with no detectable
persistence of dT-WCreCSCs (Fig. 7d). Also, the newly
formed CMs were exclusively YFPpos (4.85 ± 1.03%) with
only an occasional dTomatopos CM (< 0.01%) (Fig. 7e, f).
To test whether restoring the diploid level of c-kit
expression in the dT-WCreCSCs would correct their
myogenic and regenerative defects in vivo, we transfected
a BAC construct spanning the entire c-kit gene locus25
into cloned dT-WCreCSCs, as recently reported18. This
clone carries a single BAC/c-kit copy (hereafter dT-BACc-
kitWCreCSCs) and expresses c-kit mRNA and protein
levels similar to those of dT-wtCSCs and doubled those of
the untransfected parent c-kit/haploinsufﬁcient dT-
WCreCSCs18. Adult C57BL/6J male mice with ISO+ 5-
FU-induced cardiomyopathy were injected as above with
Fig. 6 (See legend on next page.)
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either dT-BACc-kitWCreCSCs, unedited BAC-naïve dT-
WCreCSCs, or saline. At 56 days, mice injected with dT-
WCreCSCs remained in overt HF similar to saline-injected
mice (Fig. 7g). In striking contrast and comparable to dT-
wtCSCs (Fig. 7b and Supplementary Fig. 6A), the dT-
BACc-kitWCreCSCs (n= 5) had fully restored cardiac
function (Fig. 7g). The dT-BACc-kitWCreCSCs produced
new dTomatopos CMs (~5%) in an amount similar to the
dT-wtCSCs (Fig. 7h, i). In addition, dT-BACc-
kitWCreCSCs had restored the resident CSC cohort in
the host myocardium (Fig. 7j).
Lastly, dT-wtCSCs from R26mT/mG mice were injected
into Tg-myh6MCM mice with ISO+ 5-FU cardiomyo-
pathy, fed with a TAM diet for 28 days. In this genetic
arrangement, all dTomatopos CMs (6.5 ± 2%) were
invariably only dTomatopos, with none of them co-
expressing GFP (Supplementary Fig. 7). These data rule
out cell fusion as a relevant mechanism for new CMs
contributed by the c-kitposCSCs.
Discussion
The data presented here documents that CSCs from the
c-kitCre (also named as WCre) KI mice are impaired in
their myogenic and cardiac regenerative properties
because of their c-kit hemizygosity. These defects are fully
rescued by BAC transgenesis of a single c-kit copy into
the c-kitCreCSCs to restore c-kit diploidy. On the other
hand, worsening cardiac remodelling after injury in c-
kitCre mice is reversed by the transplantation of wt c-kit+/
+CSCs. Therefore, the CSC’s myogenic and regenerative
properties are c-kit dose dependent18 and require a
diploid level of c-kit expression. For this reason, all the c-
kitCre KI mouse lines, which abolish c-kit expression from
the c-kitCreKI allele10–12, cannot and should not be used
to identify or to track the fate of the CSCs either in vitro
or in vivo.
Acute excess catecholamines directly damage the
rodent/murine heart37–41 with resultant CM death37–41.
Using ISO overdose, together with different genetic
rodent models, we had previously shown that the CSCs
are the main adult myocardium regenerative agents,
which are necessary and sufﬁcient for myocardial repair/
regeneration after damage21. Houser and colleagues42 also
reported that repair of the ISO-injured adult heart
involves the generation of new CMs derived from resident
progenitors42. This same group, however, using wild-type
and c-kitCreKI mouse models22, has recently reported to
ﬁnd no evidence of CM death or any increased CM for-
mation after ISO, raising questions about the ISO-damage
model and the role of the CSCs22.
The present study conﬁrms and extends our previous
results21, and reconciles them with those of Wallner et al.22.
The main reasons for the discordance with Wallner et al.22
are the different myocardial areas sampled (entire LV22 vs.
sub-endocardial apex21) and the type, dose, and duration of
the nucleoside analogue used to detect new cell formation.
Considering cumulative EdU dose, Wallner et al.22 under-
labelled the replicating cells by about tenfold when com-
pared with our experimental design21. The discrepancy in
the results agrees with the well-known fact that efﬁciency of
EdU and BrdU labelling of dividing cells is proportional to
the cumulative dose used43.
(see ﬁgure on previous page)
Fig. 6 Wild-type c-kitpos CSCs rescue the regenerative defect of c-kitCre mice after injury in vivo. a Bar graph with cumulative data showing the
number of dTomatopos myocytes in saline (n= 5) and ISO (n= 5) injected c-kitCre/+:R26dT/+ mice 28 days after treatment. *p < 0.05 vs. all (one-way
ANOVA analysis with Tukey’s multiple comparison test). Right, representative confocal image showing dTomatopos CMs in c-kitCre/+:R26dT/+ mice.
b Bar graph with cumulative data shows that 28 days post-ISO, the number of newly generated BrdUpos myocytes was signiﬁcantly less in c-kitCre/+:
R26dT/+ (n= 7) compared with R26dT/+ mice (n= 5). p < 0,05 vs. Saline; #p < 0,05 vs. R26dT/+ mice (one-way ANOVA analysis with Tukey’s multiple
comparison test). Right, representative confocal image showing BrdUpos CM in c-kitCre/+:R26dT/+ mice 28 days after ISO. c Representative confocal
images of cardiac cross-section showing cardiomyocyte hypertrophy in c-kitCre/+:R26dT/+ mice when compared with R26dT/+ mice (WGA, wheat
germ agglutinin, Cy5 staining, and white ﬂuorescence; cTnI, green; DAPI, blue nuclei). d Representative Masson’s trichrome staining of cardiac cross-
sections from c-kitCre/+:R26dT/+ mice 28 after ISO showing multiple areas of replacement ﬁbrosis compared with R26dT/+ mice. Scale bar= 250 μm.
e Cardiac function 28 days after ISO as assessed by Echocardiography is depressed in c-kitCre/+:R26dT/+ (n= 8) when compared with R26dT/+ mice
(n= 5). *p < 0.05 vs. all (one-way ANOVA analysis with Tukey’s multiple comparison test). f Representative confocal microscopy image showing the
absence of YFPpos CMs in cardiac Fibroblasts (cFbYFP)-injected c-kitMCM/+ mice (right insert, 3× zoom, shows the rare detection of YFPpos interstitial
non-CM cells) in the apical sub-endocardium 28 days after ISO injury. Scale bar= 50 µm. g Robust replacement of YFPpos CMs in CSCYFP-injected c-
kitMCM/+ mice in the apical sub-endocardium 28 days after ISO injury. Scale bar= 50 µm. h The two representative confocal images show the very
minimal number of YFPpos CMs (only visible in the right panel) in CSCYFP-KITKD(c-kit knock-down by speciﬁc stealth RNAi siRNA transfection)-injected
c-kitMCM/+ mice in the apical sub-endocardium 28 days after ISO injury where most of the engrafted cells remained as interstitial non-CM cells. Scale
bar= 50 µm. i Bar graph with cumulative data showing the number of YFPpos cardiomyocytes (CMs) in injured c-kitMCM/+ mice injected with saline
(n= 5), CSCYFP (n= 5), or CSCYFP-KITKD (n= 5) injected c-kitCre/+:R26dT/+mice 28 days after ISO. *p < 0.05 vs. all (one-way ANOVA analysis with Tukey’s
multiple comparison test). j Representative Masson’s Trichrome staining showing the presence of cardiac ﬁbrosis in c-kitMCM/+ mice 28 days after ISO
injected with cFBsYFP or CSCYFP-KITKD that is absent in c-kitMCM/+ mice transplanted with CSCYFP. Scale bar= 100 μm. k Cumulative data showing
Fractional Shortening as assessed by Echocardiography in c-kitMCM/+ mice at baseline and 28 days after ISO plus Saline or cFBsYFP or CSCYFP CSCYFP-
KITKD. n= 6 per group, p < 0.05 vs. Base and CSCYFP (one-way ANOVA analysis with Tukey’s multiple comparison test). Scale bars= 50 µm unless
differently speciﬁed in the panels. All data are mean ± SD
Aquila et al. Cell Death and Disease          (2019) 10:436 Page 16 of 19
Ofﬁcial journal of the Cell Death Differentiation Association
The major pitfall of the reported null CSC contribution
to new CMs after ISO in Wallner et al.22 however is due
to the use of a c-kitcreKI genetic mouse line10. The
ongoing CSC controversy has been based on two
assumptions: (a) that all the myocardial c-kitpos cells are
expected to behave like bona ﬁde CSCs10, whereas in
reality they are only ~1–2% of the c-kitpos cells;17,18 (b)
that the genetic tagging system used10–12 does in fact tags
the majority of the true c-kitposCSCs. As we have recently
shown, also the latter is incorrect18. All mouse lines with
Fig. 7 (See legend on next page.)
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Cre KIs into the c-kit locus10–12 have rendered the tar-
geted allele a null mutant with concomitant c-kit receptor
protein deﬁciency, which is equivalent to the W muta-
tion44,45. Because of the low level of c-kit expression in
most stem cell types44,46 and particularly in the c-
kitposCSCs, which have the lowest level so far detec-
ted18, the hemizygous KI Cre allele fails to produce
enough Cre to induce recombination of the marker gene
in sufﬁcient number of c-kitposCSCs to identify them,
track their fate, and, more importantly, their progeny18.
At steady state, ~95% of the CSCs in the adult mam-
malian heart are quiescent, whereas 3–5% are cycling and
differentiating21. As shown here (Fig. 5) and else-
where20,21, in rapid response to ISO damage, most CSCs
(~80%) in wt animals are rapidly activated, re-enter the
cell cycle, multiply three- to fourfold and commit to dif-
ferentiate with ample production of CMs to replace those
lost to ISO. In contrast, all c-kit hypomorphs—Wmutants
and c-kitCreKI mouse lines—show serious growth and
differentiation defects in different stem and somatic cell
types44,45, including the CSCs18. The c-kitCreCSCs have
lost their myogenic potential both in vivo (Fig. 6 and 7)
and in vitro18. These ﬁndings point towards a required
minimal level of c-kit protein for myogenicity, regen-
erative potential, and CSC niche replacement.
Based on the data presented here, this c-kit requirement
could be cell-intrinsic, extrinsic—due to effects of the
mutation on the niche or others on the myocardial
properties—or to a combination of both. The ISO+ 5-
FU-induced dilated failing cardiomyopathy of wild-type
animals can be rescued by transplantation of clone-
derived exogenous wtCSCs, which exhibit robust myo-
genic potential but not by transplantation of WCre/+CSCs
(Fig. 7). This result, together with the in vivo competition
assay between wtCSCs and the transplantation of
WCreCSCs into wt ISO+ 5-FU animals (Fig. 7) clearly
demonstrate that, although both cell types show similar
homing to the damaged myocardium when injected
through the systemic circulation, the mutant CSCs phe-
notype is not corrected in the wt myocardium, which
suggests that the defect is cell-intrinsic. This hypothesis is
conﬁrmed by the correction of the mutant phenotype and
restauration of the in vivo regenerative properties of the
WCre/+ mutant CSCs by transgenesis of a single-copy of
the c-kitwt locus, which restores their c-kit diploid state
(Fig. 7). This result is consistent with the restoration of all
the in vitro parameters tested18, which together convin-
cingly show that c-kit-expressing CSCs are capable to
regenerate the main cellular components of the adult
myocardium for which a diploid level of c-kit receptor
function is required.
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Fig. 7 c-kit haploinsufﬁciency impairs the regenerative potential of c-kitCre/+ CSCs in vivo. a Schematic of ISO+ 5-FU cardiomyopathy study
design. b LVEDD and LV Fractional Shortening representative images by Echo in male wild-type C57BL/6J mice 28 days after saline or ISO+ 5-FU
(white bars) and 56 days after ISO+ 5-FU administration treated with tail vein injections of saline (n= 6), dT-wtCSCs (n= 7), dT-WCreCSCs (n= 7), or
YFP-wtCSCs+dT-WCreCSCs (n= 6). *p < 0.05 vs. Saline and #p < 0.05 vs. ISO+ 5-FU (one-way ANOVA analysis with Tukey’s multiple comparison test).
c Myocardial ckitposCD45negCSC number in the different groups of animals as above. *p < 0.05 vs. all (except*) (one-way ANOVA analysis with Tukey’s
multiple comparison test). n= 5 for sham control (CTRL) and n= 6 for ISO+ 5-FU groups (one-way ANOVA analysis with Tukey’s multiple
comparison test). d Flow cytometric analysis of dTomatopos (or YFPpos) cell fraction within the c-kitposCD45neg CSC compartment 28 days after CSC
injections in mice with ISO+ 5-FU cardiomyopathy. N= 8 per group. e Bar graph showing cumulative data of CSC-derived Tomatopos or YFPpos CMs
in mice with ISO+ 5-FU cardiomyopathy. *p < 0.05 vs. all (n= 6) (one-way ANOVA analysis with Tukey’s multiple comparison test). f Confocal
microscopy representative images of CSC-derived newly formed dTomatopos (or YFPpos) CMs after the respective CSC injection in mice with ISO+ 5-
FU cardiomyopathy (scale bar 50 μm). In dT-wtCSC-treated hearts, CSC-derived newly formed dT(Tomato)pos CMs were several times detected as
spots of apparent clonal ampliﬁcation (mid panel). g Echocardiographic data and LV images at 56 days after ISO+ 5-FU treatment and 28 days after
either saline (n= 6), WCreCSCs (n= 6), or BACc-kitWCreCSCs (n= 5) injection; *p < 0.05 vs. all (one-way ANOVA analysis with Tukey’s multiple
comparison test). h, i Percentage of CSC-derived dTomatopos CMs in ISO+ 5-FU cardiomyopathy (left); *p < 0.05 vs. WCreCSCs (n= 6) (one-way
ANOVA analysis with Tukey’s multiple comparison test); (right) confocal microscopy representative images of CSC-derived newly formed dTomatopos
CMs after the respective CSC injection in ISO+ 5-FU cardiomyopathy. j Myocardial c-kitposCD45negCD31negCSC number in the different groups of
animals with ISO+ 5-FU cardiomyopathy. *p < 0.05 vs. all (n= 6) (one-way ANOVA analysis with Tukey’s multiple comparison test). Scale bars=
50 μm. All data are mean ± SD
Aquila et al. Cell Death and Disease          (2019) 10:436 Page 18 of 19
Ofﬁcial journal of the Cell Death Differentiation Association
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Supplementary Information accompanies this paper at (https://doi.org/
10.1038/s41419-019-1655-5).
Received: 29 October 2018 Revised: 17 April 2019 Accepted: 30 April 2019
References
1. Braunwald, E. The war against heart failure: the Lancet lecture. Lancet 385,
812–824 (2015).
2. Eschenhagen, T. et al. Cardiomyocyte regeneration. Circulation 136, 680–686
(2017).
3. Nadal-Ginard, B., Ellison, G. M. & Torella, D. The cardiac stem cell compartment
is indispensable for myocardial cell homeostasis, repair and regeneration in
the adult. Stem Cell Res. 13, 615–630 (2014).
4. Keith, M. C. L. & Bolli, R. “String Theory” of c-kit pos cardiac cells. Circ Res. 116,
1216–1230 (2015).
5. Terzic, A. & Behfar, A. CardioPulse: regenerative medicine in the practice of
cardiology. Eur Heart J 37, 1089–1090 (2016).
6. Hatzistergos, K. E. & Hare, J. M. Murine models demonstrate distinct vasculo-
genic and cardiomyogenic cKit + lineages in the heart. Circ. Res. 118, 382–387
(2016).
7. Molkentin, J. D. & Houser, S. R. Are resident c-Kit+cardiac stem cells really all
that are needed to mend a broken heart? Circ. Res. 113, 1037–1039 (2013).
8. van Berlo, J. H. & Molkentin, J. D. An emerging consensus on cardiac
regeneration. Nat. Med. 20, 1386–1393 (2014).
9. Cai, C. L. & Molkentin, J. D. The elusive progenitor cell in cardiac regeneration:
slip slidin’ away. Circ. Res. 120, 400–406 (2017).
10. van Berlo, J. H. et al. c-kit+cells minimally contribute cardiomyocytes to the
heart. Nature 509, 337–341 (2014).
11. Sultana, N. et al. Resident c-kit+cells in the heart are not cardiac stem cells.
Nat. Commun. 6, 8701 (2015).
12. Liu, Q. et al. Genetic lineage tracing identiﬁes in situ Kit-expressing cardio-
myocytes. Cell Res. 26, 119–130 (2016).
13. He, L. et al. Enhancing the precision of genetic lineage tracing using dual
recombinases. Nat. Med. 23, 1488–1498 (2017).
14. Li, Y. et al. Genetic lineage tracing of non-myocyte population by dual
recombinases. Circulation 138, 793–805 (2018).
15. Nadal-Ginard, B., Ellison, G. M. & Torella, D. Absence of evidence is not evi-
dence of absence: pitfalls of Cre knock-ins in the c-Kit locus. Circ. Res. 115,
415–418 (2014).
16. Aquila, I. et al. The use and abuse of Cre/Lox recombination to identify adult
cardiomyocyte renewal rate and origin. Pharmacol Res. 127, 116–128 (2018).
17. Vicinanza, C. et al. Adult cardiac stem cells are multipotent and robustly
myogenic: c-kit expression is necessary but not sufﬁcient for their identiﬁca-
tion. Cell Death Differ. 24, 2101–2116 (2017).
18. Vicinanza, C. et al. c-kit Cre knock-ins fail to fate-map cardiac stem cells. Nature
21, 555 (2018). E1-E5.
19. Pelliccia, F., Kaski, J. C., Crea, F. & Camici, P. G. Pathophysiology of Takotsubo
syndrome. Circulation 135, 2426–2441 (2017).
20. Ellison, G. M. et al. Acute beta-adrenergic overload produces myocyte damage
through calcium leakage from the ryanodine receptor 2 but spares cardiac
stem cells. J. Biol. Chem. 282, 11397–11409 (2007).
21. Ellison, G. M. et al. Adult c-kitpos cardiac stem cells are necessary and sufﬁcient
for functional cardiac regeneration and repair. Cell 154, 827–842 (2013).
22. Wallner, M. et al. Acute catecholamine exposure causes reversible myocyte
injury without cardiac regeneration. Circ. Res. 119, 865–879 (2016).
23. Smith, A. J. et al. Isolation and characterization of resident endogenous c-Kit
+cardiac stem cells from the adult mouse and rat heart. Nat. Protoc. 9,
1662–1681 (2014).
24. Bergmann, O. et al. Identiﬁcation of cardiomyocyte nuclei and assess-
ment of ploidy for the analysis of cell turnover. Exp. Cell Res. 317,
188–194 (2011).
25. Di Siena, S. et al. Activated c-Kit receptor in the heart promotes cardiac repair
and regeneration after injury. Cell Death Dis. 28, 7 (2016). e2317.
26. Ellison, G. M. et al. Endogenous cardiac stem cell activation by insulin-like
growth factor-1/hepatocyte growth factor intracoronary injection fosters sur-
vival and regeneration of the infarcted pig heart. J. Am. Coll. Cardiol. 58,
977–986 (2011).
27. Li, B. et al. Insulin-like growth factor-1 attenuates the detrimental impact of
nonocclusive coronary artery constriction on the heart. Circ. Res. 84,
1007–1019 (1999).
28. Luongo, T. S. et al. The mitochondrial Na+/Ca2+exchanger is essential for Ca2
+homeostasis and viability. Nature 545, 93–97 (2017).
29. Bauer, M. et al. Echocardiographic speckle-tracking based strain imaging for
rapid cardiovascular phenotyping in mice. Circ. Res. 108, 908–916
(2011).
30. Hsieh, P. C. H. et al. Evidence from a genetic fate-mapping study that stem
cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13,
970–974 (2007).
31. Loffredo, F. S., Steinhauser, M. L., Gannon, J. & Lee, R. T. Bone marrow-derived
cell therapy stimulates endogenous cardiomyocyte progenitors and promotes
cardiac repair. Cell Stem Cell 8, 389–398 (2011).
32. Hsueh, Y. C. et al. 2 promotes post-infarction cardiomyocyte replenishment by
endogenous stem cells. EMBO Mol. Med. 6, 496–503 (2014).
33. Geissler, E. N., Ryan, M. A. & Housman, D. E. The dominant-white spotting (W)
locus of the mouse encodes the c-kit proto-oncogene. Cell 55, 185–192
(1988).
34. Cimini, M. et al. c-kit dysfunction impairs myocardial healing after infarction.
Circulation 116, I77–I82 (2007).
35. Fazel, S. et al. Cardioprotective c-kit+cells are from the bone marrow and
regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116,
1865–1877 (2006).
36. Madisen, L. et al. Robust and high-throughput Cre reporting and character-
ization system for the whole mouse brain. Nat. Neurosci. 13, 133–140
(2010).
37. Teerlink, J. R., Pfeffer, J. M. & Pfeffer, M. A. Progressive ventricular remodeling in
response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ. Res.
75, 105–113 (1994).
38. Liaudet, L., Calderari, B. & Pacher, P. Pathophysiological mechanisms of cate-
cholamine and cocaine-mediated cardiotoxicity. Heart Fail. Rev. 19, 815–824
(2014).
39. Goldspink, D. F., Burniston, J. G., Ellison, G. M., Clark, W. A. & Tan, L. B.
Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myo-
cytes of the rat in vivo: the same or separate death pathways? Exp. Physiol. 89,
407–416 (2004).
40. Kassim, T. et al. Catecholamine-induced cardiomyopathy. Endocr. Pract. 14,
1137–1149 (2008).
41. Paur, H. et al. High levels of circulating epinephrine trigger apical cardiode-
pression in a β2-adrenergic receptor/Gi-dependent manner: a new model of
Takotsubo cardiomyopathy. Circulation 126, 697–706 (2012).
42. Angert, D. et al. Repair of the injured adult heart involves new myocytes
potentially derived from resident cardiac stem cells. Circ. Res. 108, 1226–1237
(2011).
43. Zeng, C. et al. Evaluation of 5-ethynyl-2’-deoxyuridine staining as a sensitive
and reliable method for studying cell proliferation in the adult nervous system.
Brain Res. 1319, 21–32 (2010).
44. Lennartsson, J. & Rönnstrand, L. Stem cell factor receptor/c-Kit: from basic
science to clinical implications. Physiol. Rev. 92, 1619–1649 (2012).
45. Bernex, F. et al. Spatial and temporal patterns of c-kit-expressing cells in
WlacZ/+and WlacZ/WlacZ mouse embryos. Development 122, 3023–3033
(1996).
46. Shin, J. Y., Hu, W., Naramura, M. & Park, C. Y. High c-Kit expression identiﬁes
hematopoietic stem cells with impaired self-renewal and megakaryocytic bias.
J. Exp. Med. 211, 217–231 (2014).
Aquila et al. Cell Death and Disease          (2019) 10:436 Page 19 of 19
Ofﬁcial journal of the Cell Death Differentiation Association
